Home » Topics » Regulatory

Regulatory
RSS

FDA approves Enbrel to treat children with moderate to severe plaque psoriasis

Nov. 7, 2016

Silvergate announces U.S. availability of Qbrelis

Oct. 27, 2016

FDA issues new approvals in NSCLC for Keytruda

Oct. 25, 2016

FDA approves Zinplava to reduce recurrence of C. difficile infection

Oct. 24, 2016

FDA grants accelerated approval for Lartruvo in soft tissue sarcoma

Oct. 20, 2016

FDA approves Tecentriq for metastatic NSCLC

Oct. 19, 2016

FDA approves infant-specific dose of Pertzye

Oct. 13, 2016

FDA approves Carnexiv as intravenous short-term replacement therapy for seizures

Oct. 10, 2016

Micatrio approved in Japan for hypertension

Oct. 3, 2016

Mikeluna approved in Japan for glaucoma and intraocular hypertension

Sep. 30, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...